Atea Pharmaceuticals, Inc. (NASDAQ:AVIR) Q4 2024 Earnings Call Transcript

Atea Pharmaceuticals, Inc. (NASDAQ:AVIR) Q4 2024 Earnings Call Transcript March 6, 2025

Atea Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS is $-0.4 EPS, expectations were $-0.35.

Operator: Good afternoon, everybody, and welcome to Atea Pharmaceuticals’ fourth quarter 2024 Financial Results and Business Update Conference Call. At this time, all participants are in a listen-only mode. Following the formal remarks, we will open the call up for your questions. I would now...